# Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial

> **NCT03037372** · PHASE3 · UNKNOWN · sponsor: **Makerere University** · enrollment: 320 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** ART, Atorvastatin
- **DRUG:** ART, Rosuvastatin
- **DRUG:** ART, No statin
- **DRUG:** Healthy-HIV-negative

## Key facts

- **NCT ID:** NCT03037372
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2017-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03037372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03037372, "Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03037372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*